z-logo
open-access-imgOpen Access
Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine
Author(s) -
J. Simon Bell,
John Bell,
Darren J. Creek
Publication year - 2020
Publication title -
australian journal of general practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 42
eISSN - 2208-794X
pISSN - 2208-7958
DOI - 10.31128/ajgp-covid-06
Subject(s) - hydroxychloroquine , pandemic , covid-19 , medicine , virology , disease , outbreak , infectious disease (medical specialty)
There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom